S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
NASDAQ:SGEN

Seagen (SGEN) Stock Forecast, Price & News

$213.70
+7.31 (+3.54%)
(As of 09/22/2023 ET)
Compare
Today's Range
$213.20
$214.00
50-Day Range
$191.57
$213.70
52-Week Range
$116.08
$214.00
Volume
3.16 million shs
Average Volume
1.42 million shs
Market Capitalization
$40.11 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$190.47

Seagen MarketRank™ Forecast

Analyst Rating
Hold
2.35 Rating Score
Upside/​Downside
10.9% Downside
$190.47 Price Target
Short Interest
Bearish
3.57% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.62
Upright™ Environmental Score
News Sentiment
0.63mentions of Seagen in the last 14 days
Based on 16 Articles This Week
Insider Trading
Selling Shares
$4.91 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($3.40) to ($1.38) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.66 out of 5 stars

Medical Sector

845th out of 963 stocks

Biological Products, Except Diagnostic Industry

132nd out of 158 stocks


SGEN stock logo

About Seagen (NASDAQ:SGEN) Stock

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. It offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of adult patients with advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-TGT and SEA-CD70 for various cancer diseases. It has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.

SGEN Price History

SGEN Stock News Headlines

Seagen, Activision Blizzard rise; Scholastic, Natural Alternatives fall, Friday, 9/22/2023
Stocks that are trading heavily or have substantial price changes on Friday: Seagen, Activision Blizzard rise; Scholastic, Natural Alternatives fall
Flee to Healthcare Stocks if Recession Rears its Head? (SGEN)
In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends.
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk
I recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.
Seagen (NASDAQ:SGEN) Reaches New 1-Year High at $214.00
Seagen gains after 'unsuprising' trial result
Why Is Seagen Stock Trading Higher Today?
Seagen, Astellas Pharma Report Positive Topline Results From EV-302 Trial
The Real Reason They Murdered JFK?
Some people believe JFK was murdered because of his executive order 11110 that would have reduced the power of the Federal Reserve. Regardless if that’s true or not… The Fed is now involved in a new controversy that could have drastic consequences for the US dollar.
Seagen Up In Pre-Market After Positive Results From EV-302 Trial
Seagen (NASDAQ:SGEN) Coverage Initiated by Analysts at StockNews.com
Seagen (SGEN) Gets a Hold from BTIG
See More Headlines
Receive SGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Seagen and its competitors with MarketBeat's FREE daily newsletter.

SGEN Company Calendar

Last Earnings
8/02/2023
Today
9/24/2023
Next Earnings (Estimated)
10/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
Biotechnology
Sector
Medical
Current Symbol
NASDAQ:SGEN
CUSIP
81257810
Employees
3,256
Year Founded
1998

Price Target and Rating

Average Stock Price Forecast
$190.47
High Stock Price Forecast
$229.00
Low Stock Price Forecast
$129.00
Forecasted Upside/Downside
-10.9%
Consensus Rating
Hold
Rating Score (0-4)
2.35
Research Coverage
17 Analysts

Profitability

Net Income
$-610,310,000.00
Pretax Margin
-32.89%

Debt

Sales & Book Value

Annual Sales
$1.96 billion
Book Value
$15.10 per share

Miscellaneous

Free Float
139,084,000
Market Cap
$40.11 billion
Optionable
Optionable
Beta
0.48

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. David R. Epstein B.Sc. (Age 61)
    M.B.A., CEO & Director
    Comp: $1.39M
  • Mr. Todd E. SimpsonMr. Todd E. Simpson (Age 62)
    Chief Financial Officer
    Comp: $1.26M
  • Dr. Vaughn B. Himes Ph.D. (Age 62)
    Chief Technical Officer
    Comp: $1.08M
  • Ms. Jean I. Liu J.D.Ms. Jean I. Liu J.D. (Age 55)
    M.S., Chief Legal Officer & Corp. Sec.
    Comp: $1.23M
  • Mr. Charles R. RompMr. Charles R. Romp (Age 55)
    Exec. VP of Commercial U.S.
    Comp: $1.08M
  • Dr. Roger D. Dansey M.D. (Age 67)
    Chief Medical Officer and Pres of R&D
    Comp: $2.48M
  • Mr. William Compton
    Sr. VP of Global Information Technology & CIO
  • Mr. David Caouette
    VP of Corp. Communications
  • Mr. Matt Skelton
    VP of Marketing
  • Ms. Peggy M. Pinkston
    Chief HR Officer













SGEN Stock - Frequently Asked Questions

Should I buy or sell Seagen stock right now?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Seagen in the last year. There are currently 11 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SGEN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SGEN, but not buy additional shares or sell existing shares.
View SGEN analyst ratings
or view top-rated stocks.

What is Seagen's stock price forecast for 2023?

17 analysts have issued 12 month price targets for Seagen's stock. Their SGEN share price forecasts range from $129.00 to $229.00. On average, they predict the company's stock price to reach $190.47 in the next year. This suggests that the stock has a possible downside of 10.9%.
View analysts price targets for SGEN
or view top-rated stocks among Wall Street analysts.

How have SGEN shares performed in 2023?

Seagen's stock was trading at $128.51 at the start of the year. Since then, SGEN shares have increased by 66.3% and is now trading at $213.70.
View the best growth stocks for 2023 here
.

When is Seagen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023.
View our SGEN earnings forecast
.

How were Seagen's earnings last quarter?

Seagen Inc. (NASDAQ:SGEN) issued its quarterly earnings data on Wednesday, August, 2nd. The biotechnology company reported ($1.13) EPS for the quarter, missing analysts' consensus estimates of ($0.78) by $0.35. The biotechnology company had revenue of $603.83 million for the quarter, compared to analyst estimates of $555.68 million. Seagen had a negative net margin of 33.54% and a negative trailing twelve-month return on equity of 26.46%.

What is Clay B. Siegall's approval rating as Seagen's CEO?

107 employees have rated Seagen Chief Executive Officer Clay B. Siegall on Glassdoor.com. Clay B. Siegall has an approval rating of 99% among the company's employees. This puts Clay B. Siegall in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Seagen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Seagen investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Gilead Sciences (GILD), Salesforce (CRM), QUALCOMM (QCOM), Tesla (TSLA), Micron Technology (MU), Netflix (NFLX) and Alibaba Group (BABA).

What is Seagen's stock symbol?

Seagen trades on the NASDAQ under the ticker symbol "SGEN."

Who are Seagen's major shareholders?

Seagen's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.42%), Capital World Investors (4.84%), Capital International Investors (3.42%), State Street Corp (1.78%), Bluefin Capital Management LLC (0.00%) and Bluefin Capital Management LLC (0.00%). Insiders that own company stock include Bros Advisors Lp Baker, Charles R Romp, Charles R Romp, Clay B Siegall, Clay B Siegall, Daniel G Welch, Daniel G Welch, David W Gryska, David W Gryska, Jean I Liu, Jean I Liu, Morgan E Obrien, Roger D Dansey, Roger D Dansey, Todd E Simpson, Todd E Simpson, Vaughn B Himes and Vaughn B Himes.
View institutional ownership trends
.

How do I buy shares of Seagen?

Shares of SGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Seagen's stock price today?

One share of SGEN stock can currently be purchased for approximately $213.70.

How much money does Seagen make?

Seagen (NASDAQ:SGEN) has a market capitalization of $40.11 billion and generates $1.96 billion in revenue each year. The biotechnology company earns $-610,310,000.00 in net income (profit) each year or ($3.89) on an earnings per share basis.

How many employees does Seagen have?

The company employs 3,256 workers across the globe.

Does Seagen have any subsidiaries?
The following companies are subsidiares of Seagen: Cascadian Therapeutics.
Read More
How can I contact Seagen?

Seagen's mailing address is 21823 30TH DRIVE SE SUITE, BOTHELL WA, 98021. The official website for the company is www.seattlegenetics.com. The biotechnology company can be reached via phone at (425) 527-4000, via email at investors@seagen.com, or via fax at 425-527-4001.

This page (NASDAQ:SGEN) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -